ID   CDON_HUMAN              Reviewed;        1287 AA.
AC   Q4KMG0; O14631;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   22-JUL-2015, entry version 101.
DE   RecName: Full=Cell adhesion molecule-related/down-regulated by oncogenes;
DE   Flags: Precursor;
GN   Name=CDON; Synonyms=CDO;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Fetal brain, and Fetal lung;
RX   PubMed=9214393; DOI=10.1083/jcb.138.1.203;
RA   Kang J.-S., Gao M., Feinleib J.L., Cotter P.D., Guadagno S.N.,
RA   Krauss R.S.;
RT   "CDO: an oncogene-, serum-, and anchorage-regulated member of the
RT   Ig/fibronectin type III repeat family.";
RL   J. Cell Biol. 138:203-213(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 826-924 IN COMPLEX WITH SHH,
RP   AND INTERACTION WITH SHH.
RX   PubMed=18794898; DOI=10.1038/nature07358;
RA   McLellan J.S., Zheng X., Hauk G., Ghirlando R., Beachy P.A.,
RA   Leahy D.J.;
RT   "The mode of Hedgehog binding to Ihog homologues is not conserved
RT   across different phyla.";
RL   Nature 455:979-983(2008).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 826-924 IN COMPLEXES WITH IHH
RP   AND DHH, AND INTERACTION WITH IHH AND DHH.
RX   PubMed=20519495; DOI=10.1074/jbc.M110.131680;
RA   Kavran J.M., Ward M.D., Oladosu O.O., Mulepati S., Leahy D.J.;
RT   "All mammalian Hedgehog proteins interact with cell adhesion molecule,
RT   down-regulated by oncogenes (CDO) and brother of CDO (BOC) in a
RT   conserved manner.";
RL   J. Biol. Chem. 285:24584-24590(2010).
RN   [6]
RP   VARIANTS HPE11 SER-684; ALA-689; MET-691; GLU-780; ALA-790 AND
RP   ARG-940.
RX   PubMed=21802063; DOI=10.1016/j.ajhg.2011.07.001;
RA   Bae G.U., Domene S., Roessler E., Schachter K., Kang J.S., Muenke M.,
RA   Krauss R.S.;
RT   "Mutations in CDON, encoding a hedgehog receptor, result in
RT   holoprosencephaly and defective interactions with other hedgehog
RT   receptors.";
RL   Am. J. Hum. Genet. 89:231-240(2011).
CC   -!- FUNCTION: Component of a cell-surface receptor complex that
CC       mediates cell-cell interactions between muscle precursor cells.
CC       Promotes differentiation of myogenic cells (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Part of a complex that contains BOC, CDON, NEO1,
CC       cadherins and CTNNB1. Interacts with NTN3 (By similarity).
CC       Interacts with PTCH1 (By similarity). Interacts with GAS1 (By
CC       similarity). Interacts with DHH, IHH and SHH. {ECO:0000250,
CC       ECO:0000269|PubMed:18794898, ECO:0000269|PubMed:20519495}.
CC   -!- INTERACTION:
CC       P00519:ABL1; NbExp=2; IntAct=EBI-7016840, EBI-375543;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q4KMG0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q4KMG0-2; Sequence=VSP_018201;
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- DISEASE: Holoprosencephaly 11 (HPE11) [MIM:614226]: A structural
CC       anomaly of the brain, in which the developing forebrain fails to
CC       correctly separate into right and left hemispheres.
CC       Holoprosencephaly is genetically heterogeneous and associated with
CC       several distinct facies and phenotypic variability.
CC       {ECO:0000269|PubMed:21802063}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Contains 3 fibronectin type-III domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00316}.
CC   -!- SIMILARITY: Contains 5 Ig-like C2-type (immunoglobulin-like)
CC       domains. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF004841; AAC34901.2; -; mRNA.
DR   EMBL; AP000821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC098583; AAH98583.1; -; mRNA.
DR   CCDS; CCDS58192.1; -. [Q4KMG0-1]
DR   CCDS; CCDS8468.1; -. [Q4KMG0-2]
DR   PIR; T03097; T03097.
DR   RefSeq; NP_001230526.1; NM_001243597.1. [Q4KMG0-1]
DR   RefSeq; NP_058648.4; NM_016952.4. [Q4KMG0-2]
DR   RefSeq; XP_011541164.1; XM_011542862.1. [Q4KMG0-1]
DR   RefSeq; XP_011541165.1; XM_011542863.1. [Q4KMG0-1]
DR   RefSeq; XP_011541166.1; XM_011542864.1. [Q4KMG0-1]
DR   RefSeq; XP_011541167.1; XM_011542865.1. [Q4KMG0-1]
DR   RefSeq; XP_011541168.1; XM_011542866.1. [Q4KMG0-2]
DR   UniGene; Hs.38034; -.
DR   PDB; 3D1M; X-ray; 1.70 A; C/D=826-924.
DR   PDB; 3N1F; X-ray; 1.60 A; C/D=826-924.
DR   PDB; 3N1Q; X-ray; 2.89 A; C/D/F=826-924.
DR   PDBsum; 3D1M; -.
DR   PDBsum; 3N1F; -.
DR   PDBsum; 3N1Q; -.
DR   ProteinModelPortal; Q4KMG0; -.
DR   SMR; Q4KMG0; 721-817, 826-924.
DR   BioGrid; 119165; 8.
DR   DIP; DIP-57226N; -.
DR   IntAct; Q4KMG0; 1.
DR   MINT; MINT-2795255; -.
DR   STRING; 9606.ENSP00000263577; -.
DR   PhosphoSite; Q4KMG0; -.
DR   BioMuta; CDON; -.
DR   DMDM; 308153422; -.
DR   MaxQB; Q4KMG0; -.
DR   PaxDb; Q4KMG0; -.
DR   PRIDE; Q4KMG0; -.
DR   Ensembl; ENST00000263577; ENSP00000263577; ENSG00000064309. [Q4KMG0-2]
DR   Ensembl; ENST00000392693; ENSP00000376458; ENSG00000064309.
DR   GeneID; 50937; -.
DR   KEGG; hsa:50937; -.
DR   UCSC; uc001qdc.4; human. [Q4KMG0-2]
DR   UCSC; uc009zbw.3; human. [Q4KMG0-1]
DR   CTD; 50937; -.
DR   GeneCards; GC11M125866; -.
DR   H-InvDB; HIX0035847; -.
DR   HGNC; HGNC:17104; CDON.
DR   HPA; CAB012422; -.
DR   HPA; HPA017377; -.
DR   MIM; 608707; gene.
DR   MIM; 614226; phenotype.
DR   neXtProt; NX_Q4KMG0; -.
DR   Orphanet; 93925; Alobar holoprosencephaly.
DR   Orphanet; 93924; Lobar holoprosencephaly.
DR   Orphanet; 280200; Microform holoprosencephaly.
DR   Orphanet; 93926; Midline interhemispheric variant of holoprosencephaly.
DR   Orphanet; 220386; Semilobar holoprosencephaly.
DR   Orphanet; 280195; Septopreoptic holoprosencephaly.
DR   PharmGKB; PA26328; -.
DR   eggNOG; NOG150729; -.
DR   GeneTree; ENSGT00800000124026; -.
DR   HOGENOM; HOG000060072; -.
DR   HOVERGEN; HBG081073; -.
DR   InParanoid; Q4KMG0; -.
DR   OMA; VSDTQIM; -.
DR   OrthoDB; EOG7MD4PB; -.
DR   PhylomeDB; Q4KMG0; -.
DR   TreeFam; TF332268; -.
DR   Reactome; REACT_21402; CDO in myogenesis.
DR   Reactome; REACT_268573; Ligand-receptor interactions.
DR   ChiTaRS; CDON; human.
DR   EvolutionaryTrace; Q4KMG0; -.
DR   GeneWiki; CDON; -.
DR   GenomeRNAi; 50937; -.
DR   NextBio; 53379; -.
DR   PRO; PR:Q4KMG0; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; Q4KMG0; -.
DR   CleanEx; HS_CDON; -.
DR   ExpressionAtlas; Q4KMG0; baseline and differential.
DR   Genevisible; Q4KMG0; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; TAS:UniProtKB.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0010172; P:embryonic body morphogenesis; IEA:Ensembl.
DR   GO; GO:0060059; P:embryonic retina morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:0002088; P:lens development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0042692; P:muscle cell differentiation; TAS:Reactome.
DR   GO; GO:0007520; P:myoblast fusion; IEA:Ensembl.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0051057; P:positive regulation of small GTPase mediated signal transduction; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0043497; P:regulation of protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0014816; P:skeletal muscle satellite cell differentiation; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 3.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 4.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Disulfide bond; Glycoprotein; Holoprosencephaly;
KW   Immunoglobulin domain; Membrane; Polymorphism; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   1287       Cell adhesion molecule-related/down-
FT                                regulated by oncogenes.
FT                                /FTId=PRO_0000234054.
FT   TOPO_DOM     26    963       Extracellular. {ECO:0000255}.
FT   TRANSMEM    964    984       Helical. {ECO:0000255}.
FT   TOPO_DOM    985   1287       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       29    114       Ig-like C2-type 1.
FT   DOMAIN      120    204       Ig-like C2-type 2.
FT   DOMAIN      225    303       Ig-like C2-type 3.
FT   DOMAIN      310    396       Ig-like C2-type 4.
FT   DOMAIN      405    516       Ig-like C2-type 5.
FT   DOMAIN      579    677       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      723    821       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      826    926       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   CARBOHYD     88     88       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    100    100       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    180    180       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    287    287       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    294    294       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    427    427       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    570    570       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    873    873       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID     50     97       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    141    191       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    243    290       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    333    380       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    426    500       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ    1212   1234       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9214393}.
FT                                /FTId=VSP_018201.
FT   VARIANT      66     66       K -> R (in dbSNP:rs7122277).
FT                                /FTId=VAR_056038.
FT   VARIANT     162    162       E -> K (in dbSNP:rs3740909).
FT                                /FTId=VAR_056039.
FT   VARIANT     351    351       P -> A (in dbSNP:rs35665264).
FT                                /FTId=VAR_056040.
FT   VARIANT     684    684       T -> S (in HPE11; dbSNP:rs145983470).
FT                                {ECO:0000269|PubMed:21802063}.
FT                                /FTId=VAR_066497.
FT   VARIANT     686    686       A -> V (in dbSNP:rs12274923).
FT                                /FTId=VAR_056041.
FT   VARIANT     689    689       P -> A (in HPE11).
FT                                {ECO:0000269|PubMed:21802063}.
FT                                /FTId=VAR_066498.
FT   VARIANT     691    691       V -> M (in HPE11).
FT                                {ECO:0000269|PubMed:21802063}.
FT                                /FTId=VAR_066499.
FT   VARIANT     780    780       V -> E (in HPE11).
FT                                {ECO:0000269|PubMed:21802063}.
FT                                /FTId=VAR_066500.
FT   VARIANT     790    790       T -> A (in HPE11).
FT                                {ECO:0000269|PubMed:21802063}.
FT                                /FTId=VAR_066501.
FT   VARIANT     940    940       S -> R (in HPE11).
FT                                {ECO:0000269|PubMed:21802063}.
FT                                /FTId=VAR_066502.
FT   CONFLICT     75     75       V -> I (in Ref. 1; AAC34901 and 3;
FT                                AAH98583). {ECO:0000305}.
FT   CONFLICT    265    265       G -> E (in Ref. 3; AAH98583).
FT                                {ECO:0000305}.
FT   CONFLICT    300    300       K -> E (in Ref. 1; AAC34901).
FT                                {ECO:0000305}.
FT   CONFLICT    669    669       L -> I (in Ref. 1; AAC34901).
FT                                {ECO:0000305}.
FT   CONFLICT   1244   1244       I -> N (in Ref. 3; AAH98583).
FT                                {ECO:0000305}.
FT   STRAND      831    837       {ECO:0000244|PDB:3N1F}.
FT   STRAND      839    841       {ECO:0000244|PDB:3N1F}.
FT   STRAND      843    848       {ECO:0000244|PDB:3N1F}.
FT   HELIX       852    854       {ECO:0000244|PDB:3N1F}.
FT   STRAND      861    868       {ECO:0000244|PDB:3N1F}.
FT   HELIX       874    876       {ECO:0000244|PDB:3N1F}.
FT   STRAND      878    883       {ECO:0000244|PDB:3N1F}.
FT   STRAND      887    891       {ECO:0000244|PDB:3N1F}.
FT   STRAND      899    908       {ECO:0000244|PDB:3N1F}.
FT   STRAND      919    922       {ECO:0000244|PDB:3N1F}.
SQ   SEQUENCE   1287 AA;  139147 MW;  B7870C66F5224BBE CRC64;
     MHPDLGPLCT LLYVTLTILC SSVSSDLAPY FTSEPLSAVQ KLGGPVVLHC SAQPVTTRIS
     WLHNGKTLDG NLEHVKIHQG TLTILSLNSS LLGYYQCLAN NSIGAIVSGP ATVSVAVLGD
     FGSSTKHVIT AEEKSAGFIG CRVPESNPKA EVRYKIRGKW LEHSTENYLI LPSGNLQILN
     VSLEDKGSYK CAAYNPVTHQ LKVEPIGRKL LVSRPSSDDV HILHPTHSQA LAVLSRSPVT
     LECVVSGVPA PQVYWLKDGQ DIAPGSNWRR LYSHLATDSV DPADSGNYSC MAGNKSGDVK
     YVTYMVNVLE HASISKGLQD QIVSLGATVH FTCDVHGNPA PNCTWFHNAQ PIHPSARHLT
     AGNGLKISGV TVEDVGMYQC VADNGIGFMH STGRLEIEND GGFKPVIITA PVSAKVADGD
     FVTLSCNASG LPVPVIRWYD SHGLITSHPS QVLRSKSRKS QLSRPEGLNL EPVYFVLSQA
     GASSLHIQAV TQEHAGKYIC EAANEHGTTQ AEASLMVVPF ETNTKAETVT LPDAAQNDDR
     SKRDGSETGL LSSFPVKVHP SAVESAPEKN ASGISVPDAP IILSPPQTHT PDTYNLVWRA
     GKDGGLPINA YFVKYRKLDD GVGMLGSWHT VRVPGSENEL HLAELEPSSL YEVLMVARSA
     AGEGQPAMLT FRTSKEKTAS SKNTQASSPP VGIPKYPVVS EAANNNFGVV LTDSSRHSGV
     PEAPDRPTIS TASETSVYVT WIPRANGGSP ITAFKVEYKR MRTSNWLVAA EDIPPSKLSV
     EVRSLEPGST YKFRVIAINH YGESFRSSAS RPYQVVGFPN RFSSRPITGP HIAYTEAVSD
     TQIMLKWTYI PSSNNNTPIQ GFYIYYRPTD SDNDSDYKRD VVEGSKQWHM IGHLQPETSY
     DIKMQCFNEG GESEFSNVMI CETKVKRVPG ASEYPVKDLS TPPNSLGSGG NVGPATSPAR
     SSDMLYLIVG CVLGVMVLIL MVFIAMCLWK NRQQNTIQKY DPPGYLYQGS DMNGQMVDYT
     TLSGASQING NVHGGFLTNG GLSSGYSHLH HKVPNAVNGI VNGSLNGGLY SGHSNSLTRT
     HVDFEHPHHL VNGGGMYTAV PQIDPLECVN CRNCRNNNRC FTKTNSTFSS SPPPVVPVVA
     PYPQDGLEMK PLSHVKVPVC LTSAVPDCGQ LPEESVKDNV EPVPTQRTCC QDIVNDVSSD
     GSEDPAEFSR GQEGMINLRI PDHLQLAKSC VWEGDSCAHS ETEINIVSWN ALILPPVPEG
     CAEKTMWSPP GIPLDSPTEV LQQPRET
//
